Bioconjugate Chemistry,
Год журнала:
2024,
Номер
35(7), С. 867 - 882
Опубликована: Июнь 26, 2024
Cancer
immunotherapy
has
yielded
remarkable
results
across
a
variety
of
tumor
types.
Nevertheless,
the
complex
and
immunosuppressive
microenvironment
within
solid
tumors
poses
significant
challenges
to
established
therapies
such
as
immune
checkpoint
blockade
(ICB)
chimeric
antigen
receptor
T-cell
(CAR-T)
therapy.
Within
milieu,
tumor-associated
macrophages
(TAMs)
play
role
by
directly
suppressing
functionality
fostering
an
environment.
Effective
regulation
TAMs
is,
therefore,
crucial
enhancing
efficacy
immunotherapies.
Various
therapeutic
strategies
targeting
TAM
modulation
have
emerged,
including
blocking
recruitment,
direct
elimination,
promoting
repolarization
toward
M1
phenotype,
phagocytic
capacity
against
cells.
The
recently
introduced
CAR
macrophage
(CAR-M)
therapy
opens
new
possibilities
for
macrophage-based
immunotherapy.
Compared
with
CAR-T,
CAR-M
may
demonstrate
superior
infiltration
capabilities
tumors.
This
review
predominantly
delves
into
origin
development
process
TAMs,
their
in
growth,
provides
comprehensive
overview
immunotherapies
TAMs.
It
underscores
significance
regulating
bolstering
antitumor
while
discussing
potential
developing
targets
ABSTRACT
Metastasis
remains
a
leading
cause
of
cancer‐related
deaths,
defined
by
complex,
multi‐step
process
in
which
tumor
cells
spread
and
form
secondary
growths
distant
tissues.
Despite
substantial
progress
understanding
metastasis,
the
molecular
mechanisms
driving
this
development
effective
therapies
remain
incompletely
understood.
Elucidating
pathways
governing
metastasis
is
essential
for
discovery
innovative
therapeutic
targets.
The
rapid
advancements
sequencing
technologies
expansion
biological
databases
have
significantly
deepened
our
drivers
associated
drug
resistance.
This
review
focuses
on
particularly
roles
genetic
mutations,
epigenetic
changes,
post‐translational
modifications
progression.
We
also
examine
how
microenvironment
influences
metastatic
behavior
explore
emerging
strategies,
including
targeted
immunotherapies.
Finally,
we
discuss
future
research
directions,
stressing
importance
novel
treatment
approaches
personalized
strategies
to
overcome
improve
patient
outcomes.
By
integrating
contemporary
insights
into
basis
innovation,
provides
comprehensive
framework
guide
clinical
cancer.
Clinical and Translational Medicine,
Год журнала:
2025,
Номер
15(3)
Опубликована: Фев. 25, 2025
Abstract
Background
Macrophages
have
been
shown
to
contribute
renal
injury
and
fibrosis
as
well
repair.
Recently,
Triggering
Receptor
Expressed
on
Myeloid
Cells
2
(TREM2)‐positive
macrophages
play
important
roles
in
regulating
tissue
inflammation
However,
it
remains
unclear
whether
they
can
mitigate
the
transition
from
acute
kidney
chronic
disease
(the
AKI–CKD
transition).
Methods
The
was
generated
by
unilateral
ischaemia–reperfusion
(UIRI)
wild‐type
(WT)
Trem2
knockout
mice.
F4/80
magnetic
beads
were
used
isolate
macrophages.
Flow
cytometry
determine
levels
of
TREM2
CD11b
levels.
Quantitative
reverse
transcription
polymerase
chain
reaction
(qRT‐PCR),
Western
blotting
histological
staining
performed
expression
cytokines
fibrotic
markers.
RNA‐seq
investigate
transcriptomic
changes
between
WT
bone
marrow‐derived
(BMDMs).
TREM2‐overexpressing
using
lentivirus
transferred
intravenously
UIRI
Results
exhibited
a
strong
protective
effect
transition.
Genetic
deletion
resulted
increased
exacerbated
Interestingly,
we
found
that
hypoxia
could
increase
via
HIF‐1α.
Upregulated
enhanced
macrophage
phagocytosis
suppressed
pro‐inflammatory
cytokines,
resulting
lower
apoptosis
tubular
epithelial
cells.
Using
analysis,
showed
regulatory
effects
orchestrated
PI3K‐AKT
pathway.
Pharmacological
regulation
pathway
modulate
macrophage‐mediated
phagocytosis.
In
addition,
an
adoptive
cell
therapy
effectively
reduced
immune
infiltration,
Conclusion
Our
study
not
only
provides
valuable
mechanistic
insights
into
role
but
also
offers
new
avenue
for
macrophage‐based
treat
diseases.
Key
points
worsens
accelerates
is
upregulated
HIF1α
An
reduces
fibrosis.
iScience,
Год журнала:
2023,
Номер
26(7), С. 107201 - 107201
Опубликована: Июнь 25, 2023
Intrauterine
adhesion
(IUA)
is
a
common
cause
of
uterine
infertility
and
its
histopathologic
characteristic
endometrial
fibrosis.
A
shortage
stem
cells
in
the
basalis
has
been
recognized
as
IUA
development
because
approximately
90%
patients
suffer
from
after
injury.
In
this
study,
we
provide
evidence
that
persistent
inflammation
main
contributor
to
fibrosis
patients.
We
further
found
treating
an
IUA-like
mouse
model
with
ITI-hUC-MSCs
(hUC-MSCs
reprogrammed
by
IL-1β,
TNF-α
IFN-γ)
significantly
decreased
Mechanistically,
high
levels
complement
1
inhibitor
(C1INH)
secreted
prevented
inducing
profibrotic
CD301+
macrophage
polarization
downregulating
JAK-STAT
signaling
pathway.
conclusion,
endometria
provides
niche
promote
fibrosis,
powerful
immunomodulatory
effects
improve
immune
microenvironment
regeneration.
Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Май 20, 2024
Abstract
Rheumatoid
arthritis
(RA)
is
a
chronic
autoimmune
disease
of
yet
undetermined
etiology
that
accompanied
by
significant
oxidative
stress,
inflammatory
responses,
and
damage
to
joint
tissues.
In
this
study,
we
designed
chondroitin
sulfate
(CS)-modified
tragacanth
gum–gelatin
composite
nanocapsules
(CS-Cur-TGNCs)
loaded
with
curcumin
nanocrystals
(Cur-NCs),
which
rely
on
the
ability
CS
target
CD44
accumulate
drugs
in
inflamed
joints.
Cur
was
encapsulated
form
into
(TGNCs)
using
an
inborn
microcrystallization
method,
produced
CS-Cur-TGNCs
particle
size
approximately
80
±
11.54
nm
drug
loading
capacity
54.18
5.17%.
vitro
release
assay,
showed
MMP-2-responsive
properties.
During
treatment
RA,
significantly
inhibited
promoted
polarization
M2-type
macrophages
M1-type
macrophages,
decreased
expression
factors
(TNF-α,
IL-1β,
IL-6).
addition,
it
also
exerted
excellent
anti-inflammatory
effects,
alleviated
swelling
joints
during
gouty
(GA).
Therefore,
CS-Cur-TGNCs,
as
novel
delivery
system,
could
lead
new
ideas
for
clinical
therapeutic
regimens
RA
GA.
Graphical
Advanced Functional Materials,
Год журнала:
2024,
Номер
34(26)
Опубликована: Янв. 9, 2024
Abstract
In
situ
tumor
vaccines
(ISTVs)
hold
great
potential
in
immunotherapy,
however,
three
major
obstacles,
including
inadequate
endogenous
antigen
uptake
by
dendritic
cells
(DCs),
weak
T‐cell
immune
responses,
and
stubborn
immunosuppressive
microenvironment
(TME),
still
need
to
be
fully
addressed.
Herein,
a
trifecta
nanovaccine
(TriNV)
with
TME‐responsive
transformable
ability
is
developed
tri‐boost
antitumor
immunity.
First,
sufficient
tumor‐associated
antigens
(TAAs)
are
liberated
after
immunogenic
cell
death
induced
via
TriNV‐based
photoimmunotherapy.
the
TME,
soft‐transformed
TriNV
improves
of
TAAs
DCs
enhance
acquired
Second,
self‐adjuvating
released
Mn
2+
synergistically
promote
DC
maturation
macrophage
M1
polarization
augmenting
stimulator
interferon
genes
activation
further
amplify
responses.
Moreover,
decomposition
MnO
2
within
core
exhausts
glutathione
facilitates
O
release
alleviate
hypoxia
thereby
overcoming
chemical
obstacles
TME
mitigate
immunosuppression.
Thus,
remarkably
eradicates
primary
tumors
inhibits
distant
metastasis,
thus
demonstrating
as
feasible
effective
ISTV
nanoplatform
for
combating
poorly
solid
tumors.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Окт. 4, 2023
Nonalcoholic
fatty
liver
disease
(NAFLD)
and
its
inflammatory
often
progressive
subtype
nonalcoholic
steatohepatitis
(NASH),
have
emerged
as
significant
contributors
to
hepatic
morbidity
worldwide.
The
pathophysiology
of
NAFLD/NASH
is
multifaceted,
variable,
remains
incompletely
understood.
pivotal
role
liver-resident
recruited
macrophages
in
the
pathogenesis
NAFLD
NASH
widely
acknowledged
a
crucial
factor
innate
immunity.
remarkable
plasticity
enables
them
assume
diverse
activation
polarization
states,
dictated
by
their
immunometabolism
microenvironment
functional
requirements.
Recent
studies
field
elucidated
that
alterations
metabolic
profile
can
profoundly
influence
state
functionality,
thereby
influencing
various
pathological
processes.
This
review
primarily
focuses
on
elucidating
states
macrophages,
highlighting
correlation
between
characteristics
transition
from
pro-inflammatory
anti-inflammatory
phenotypes.
Additionally,
we
explore
potential
targeting
macrophage
metabolism
promising
therapeutic
approach
for
management
NAFLD/NASH.
Abstract
Macrophage
therapy
for
liver
fibrosis
is
on
the
cusp
of
meaningful
clinical
utility.
Due
to
heterogeneities
macrophages,
it
urgent
develop
safer
macrophages
with
a
more
stable
and
defined
phenotype
treatment
fibrosis.
Herein,
new
macrophage‐based
immunotherapy
using
stably
expressing
pivotal
cytokine
from
Toxoplasma
gondii
,
parasite
that
infects
≈
2
billion
people
developed.
It
found
macrophage
migration
inhibitory
factor‐transgenic
(Mφ
tgmif
)
shows
fibrinolysis
strong
chemotactic
capacity.
Mφ
effectively
ameliorates
deactivates
aHSCs
by
recruiting
Ly6C
hi
via
paracrine
CCL2
polarizing
them
into
restorative
lo
through
secretion
CX3CL1.
Remarkably,
exhibits
even
higher
potential,
lower
grade
inflammation,
better
therapeutic
effects
than
LPS/IFN‐γ‐treated
making
immune
efficient
safer.
Mechanistically,
Tg
MIF
promotes
expression
activating
ERK/HMGB1/NF‐κB
pathway,
this
event
associated
endogenous
liver.
The
findings
do
not
merely
identify
viable
but
also
suggest
strategy
based
evolutionarily
designed
immunomodulator
treat
human
diseases
modifying
microenvironment.
Cells,
Год журнала:
2022,
Номер
11(23), С. 3890 - 3890
Опубликована: Дек. 2, 2022
Tumour-associated
macrophages
(TAMs)
are
essential
players
in
the
tumour
microenvironment
(TME)
and
modulate
various
pro-tumorigenic
functions
such
as
immunosuppression,
angiogenesis,
cancer
cell
proliferation,
invasion
metastasis,
along
with
resistance
to
anti-cancer
therapies.
TAMs
also
mediate
important
anti-tumour
can
clear
dying
cells
via
efferocytosis.
Thus,
not
surprisingly,
exhibit
heterogeneous
activities
functional
plasticity
depending
on
type
context
of
death
that
they
faced
with.
This
ultimately
governs
both
anti-tumorigenic
activity
TAMs,
making
interface
between
very
for
modulating
growth
efficacy
chemo-radiotherapy
or
immunotherapy.
In
this
review,
we
discuss
from
perspectives
pathways,
TME-driven
variations,
TAM
heterogeneity
cell-death-inducing
We
believe
a
better
understanding
how
influence
lead
improved
combinatorial
therapies,
especially
combination
TAM-targeting
immunotherapies.
Journal of Cellular Physiology,
Год журнала:
2023,
Номер
238(10), С. 2243 - 2252
Опубликована: Сен. 24, 2023
Abstract
The
high
incidence,
low
healing
rate
and
huge
economic
burden
of
wounds
(especially
chronic
wounds)
worldwide
remain
a
great
challenge
for
clinical
staff
patients.
various
stages
wound
are
regulated
by
paracrine
or
autocrine
cytokines
growth
factors,
the
study
their
intrinsic
mechanisms
is
prerequisite
better
treatment.
Lactate,
end
product
glycolysis,
plays
role
in
all
healing,
recent
studies
have
identified
lactate
as
an
epigenetic
regulator
that
regulates
gene
expression
through
histone
lysine
lactylation
stimulates
posttranslational
modifications
to
regulate
related
expression,
thereby
causing
series
biological
functional
changes.
This
article
reviews
progress
research
on
during
diseases,
including
its
involvement
immune
regulation,
inflammation
control,
proliferative
remodeling,
finally
describes
prospects
therapy
regarding
healing.